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 Rearrangement of the antigen-specific lymphocyte receptor 
genes generates repertoire of T and B cells that can attack 
any emerging pathogens as well as host tissue itself. This 
horror autotoxicus has to be removed by mechanisms collec-
tively called self-tolerance. Recent advances in immunological 
science revealed that there are multiple mechanisms of tol-
erance both in central and peripheral organs. However, it 
has become more and more apparent that cellular mecha-
nisms that induce tolerance (inactivation) and activation of 
lymphocytes are quite similar. Possible mechanisms by which 
immune system distinguishes self-structure from pathogens 
will be discussed.
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any unexpected pathogen is the possibility of attack-
ing its own tissue. It is necessary to deplete or inacti-
vate lymphocytes that recognize self-tissue before it at-
tacks their own tissue to prevent self-destruction. This 
process, which is called immunological self-tolerance, oc-
curs during the generation of the lymphocytes in the 
primary lymphoid organs (central tolerance) as well 
as in peripheral tissue (peripheral tolerance). This re-
view deals mainly with the current understanding of 
the mechanisms of T cell tolerance in relation to the 
host defense against invading pathogens. I will mainly 
focus on the issues on the peripheral tolerance, which 
is not completely revealed but is important for our 
understanding of how immune system distinguishes 
pathogen-derived antigens from bunch of self-antigens.
T cell antigen recognition and activation/ inacti-
vation
Introduction
 Immune system is designed to combat against the 
invasion of varieties of microbes into the body. This 
system has been evolved over many years adapting to 
the alterations in the environmental microorganisms and 
preparing for the emergence of any novel pathogens. 
The main cell types of the immune system, which highly 
evolved for this purpose, are T- and B-lymphocytes. 
During the initial phase of the lymphocyte development, 
rearrangement of the antigen receptors in lymphocyte 
precursors occurs randomly, creating a huge repertoire of 
lymphocytes each expressing a distinct antigen-receptor. 
As a result, these lymphocyte precursors develop into 
cells that can recognize self-structure as well as patho-
gens. Therefore, the expense to prepare dealing with
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 Unlike B cells, which recognize conformational struc-
ture of the antigen by immunoglobulin receptor on cell 
surface, T cells are designed to recognize peptides buried 
in the groove of MHC expressed on antigen presenting 
cells (APC). This difference in antigen recognition be-
tween B and T cells derives from the difference in the 
location of the target microbes that they recognize; T 
lymphocytes attack pathogens associated with cells, 
while B-lymphocytes are designed to produce antibod-
ies that attack microorganisms outside of cells. The re-
quirement of the recognition of cell-associated patho-
gens resulted in the presentation of antigen in associa-
tion with the major histocompatibility antigen complex 
(MHC) to T cells. In this way, T cells can recognize 
pathogens invading inside of cells. There are two types 
of MHC, class I and class II; MHC class I molecules as-
sociate with peptides derived from cytoplasm while MHC 
class II associate with peptides derived from molecules 
engulfed by phagocytosis or endocytosis. T cell recep-
tor (TCR) is designed to recognize peptides associated 
with MHC. Thus, T cells does not have to be tolerized 
to all self-structure. It only needs tolerized to peptides
buried in the MHC groove.
Professional Antigen Presenting Cells
 When T cells recognize the right peptide/MHC on 
APC, they are activated and differentiate into func-
tional T cell subset, or deliver their effector function 
such as cytokine secretion and cytolysis. However, naive 
T cells, which are mature but have not been encoun-
tered the relevant peptide/MHC in the periphery, can-
not be activated by the recognition of peptide / MHC 
alone. They need a second signal delivered by APC in 
addition to a TCR-mediated signal for full activation 
(Fig. 1). It is believed that T cells become unrespon-
sive to subsequent stimulation if they recognize right 
MHC/peptide without delivery of the second signal''. 
Those APC, which can activate naive T cells, are called 
professional APC. They include dendritic cells, acti-
vated macrophages and activated B cells.
murine lymphoid organs can be identified by their ex-
pression of the integrin CD11c3•". They include veiled 
cells in afferent lymphatics, interdigitating cells in the 
thymus, dermal dendrocytes, epidermal Langerhans cells 
as well as lymphoid dendritic cells in peripheral lym-
phoid tissue and blood. Recent studies revealed that 
dendritic cells are not homogeneous. They can be divided 
into two groups by their expression of CD8 molecule 
on cell surface"". The typical dendritic cells do not ex-
press CD8 and are myeloid origin, and is dependent on 
GM-CSF for growth. They collect antigens in the pe-
ripheral site, migrate to the secondary lymphoid organ, 
and activate specific T cells. They include dendritic cells 
of Langerhans and monocyte / macrophage lineages. 
Dendritic cells expressing CD8 have been identified re-
cently. They derive from lymphoid-restricted progeni-
tors" and are CD8+DEC-205+CD119-5'. These cells are 
present in both thymus and lymph nodes, express Fas 
ligand, and can induce apoptosis in reactive T cells, sug-
gesting that these dendritic cells might have regulatory 
function". These cells are not dependent on GM-CSF9'.
Antigen expressed in non-professional APC
 Naive T cells, which migrate to the periphery out 
of thymus, recirculate through lymphatics and blood 
(Fig. 2)10,"). They are activated when they recognize 
antigenic peptide/MHC presented by professional APC 
in the secondary lymphoid organs. Thus, peripheral anti-
gens have to be carried to the draining lymph nodes 
to prime T cells. Microbes invading inside the skin, for
Fig. 1 
Two signal model of T cell activation. 
Two signals are required for full T cell activation. First sig-
nal is delivered by the occupancy of TCR by MHC/peptide. 
Second signal, which is called costimulation, is delivered by 
the occupancy of CD28 by B7 molecules etc. Professional APC 
express these costimulatory molecules and can fully activate 
T cells. Non-professional APC lack the ability to deliver the 
second signal. Occupancy of TCR without delivery of the second 
signal is believed to lead inactivation of the T cells.
 The most efficient professional APC are dendritic 
cells". In fact, the only known function of dendritic 
cells is the presentation of antigen to T cells. Dendritic 
cells are derived from bone marrow and express high 
levels of both MHC class I and class II as well as adhesion 
and costimulatory molecules. Mature dendritic cells from
Fig. 2 
Recirculation of naive T cells. 
Naive T cells recirculate through lymphatics and blood, and 
do not migrate to the periphery. Peripheral antigens have to 
be carried to the draining lymph nodes to prime specific 
naive T cells.
example, will be taken up by Langerhans' cells, which 
migrate to the draining lymph nodes, where they acti-
vate specific T cells. In general, macrophages or imma-
ture dendritic cells have phagocytic function. They take 
up peripheral antigens by phagocytosis or endocytosis 
and present them to T cells in association with MHC 
class II molecules. How are antigens derived from mi-
crobes that invade intracellular compartment presented 
to T cells? When professional APC are infected by 
virus, they can present viral peptide derived from the 
cytoplasm in the context of MHC class I, and activate 
specific CD8 T cells (Fig. 1). However, not every intra-
cellular microbe can infect professional APC. Many mi-
crobes are tissue tropic and infect only a particular tis-
sue, which is often of non-hematopoietic origin. For 
example, hepatitis virus or liver-stage malaria only in-
fects hepatocytes while influenza virus infects respira-
tory epithelium. They do not infect professional APC, 
but specific cytotoxic T cell response is induced in the 
infected individual. How do pathogen-derived antigens 
have access to MHC class I antigen presentation path-
way, and activate naive CD8 T cells? Recent evidence 
indicates that these cells do not directly activate CD8 
cells; instead, antigens derived from intracellular microbes 
are somehow taken up by professional APC and are 
presented in association with MHC class I molecules"'. 
This type of indirect priming of T cells by profes-
sional APC is called cross-priming (Fig. 3).
of MHC-mismatched cells to prime minor histocompati-
bility antigen specific cytotoxic T cell responses was 
reported 13,M). The term cross-priming is now more widely 
used to describe the priming of CD8 T cells by exogenous 
antigens. It appears that exogenous antigens are some-
how internalized, digested by cytoplasmic proteasome, 
and transported into endoplasmic reticulum through Tap 
molecule where the antigenic peptides binds to MHC 
class I molecules"). Examples of cross-priming has been 
accumulating. In addition to the priming with minor 
histocompatibility antigens, cell-associated") or particu 
late antigens 11,18,19> are effective antigens for cross-priming. 
Antigens associates with cells undergoing apoptosis also 
can be taken up by APC and presented in the context of 
MHC class I molecules"). It was clearly demonstrated that 
cells of the hematopoietic lineage, most likely profes-
sional APC, mediate priming of the naive T cells against 
tissue-tropic virus"). Furthermore, presentation of exoge-
nous antigen by class I pathway appear to take place not 
only for foreign antigens but also for self-antigens"). In 
transgenic mouse model in which membrane bound form 
of ovalbumin (OVA) was expressed in pancreatic /9 cells, 
specific T cells were activated by cross-priming of OVA 
by bone marrow derived APC.
 The molecular basis of cross-priming is poorly un-
derstood. One of the candidate molecules, which may 
be involved in this process, is heat-shock protein. Heat-
shock protein gp96 or hsp70 purified from tumor cells 
associate with tumor specific antigenic peptides and can 
induce specific cytotoxic T cell responses and protec-
tive immunity against the original cancer","). Similarly, 
heat shock protein gp96 was shown associated with 
dominant viral peptide"), and also can prime minor 
histocompatibility antigen-specific T cells26'. It is likely 
that heat shock protein derived from non-professional 
APC is involved in the process of cross-priming.
Fig. 3 
Cross-priming. 
Non-professional APC cannot directly activate naive T cells. 
Cytosolic antigens in non-professional APC, such as viral prod-
ucts, are somehow presented to naive T cells by MHC class 
I antigen presentation pathway of professional APC. Once ac-
tivated, naive T cells differentiate into effector T cells, which 
can recognize MHC/peptide on non-professional APC.
 The concept of cross-priming is not new. It was origi-
nally described more than 20 years ago when the ability
 The second point that should be considered in prim-
ing naive T cells by antigens expressed in peripheral 
tissue is circulation of naive T cells (Fig. 2). Naive T 
cells recirculate through secondary lymphoid organs and 
do not migrate into peripheral tissue'o,1i) Therefore, naive 
T cells do not have opportunity to contact antigens ex-
pressed in' peripheral tissue alone, unless they are trans-
ported into the secondary lymphoid organs. When the 
peripheral tissue is infected with microbes, the local envi-
ronment is altered by the initial innate immune re-
sponses resulting in activation of dendritic cells, which 
migrate to the regional lymph nodes where they activate 
naive T cells (Fig. 2). This migration of dendritic cells, 
however, may occur constantly without local inflamma-
tion. This possibility was suggested in an experimental
model system using transgenic mice"'. OVA-specific CD8 
cells from the TCR transgenic mice were injected into 
transgenic mice, which express a membrane-bound form 
of OVA in the pancreatic islet j9 cells and kidney. 
Transgenic T cells specifically accumulated in the drain-
ing lymph nodes of pancreas and kidney, and they 
showed activated phenotype indicating that tissue-
associated neo-self antigen can be constantly presented 
by MHC class I pathway in the draining lymph nodes. 
Therefore, at least under certain conditions, not only 
pathogen-derived antigens but also self-antigens in non-
lymphoid tissue can be presented to naive recirculating 
T cells.
Central Tolerance
  The most important organ where self-reactivity of 
lymphocytes is controlled is the thymus, the very 
organ in which T cells are generated. This control is 
mainly performed by apoptosis of T cells expressing 
high affinity TCR for MHC/self-peptide and is called 
negative selection. Antigen encounter of lymphocytes at 
this stage results in death or anergy induction rather 
than activation. The deletion of self-reactive thymocytes 
was clearly shown by using TCR transgenic mouse 
models","' and superantigen system"'. 
 The most efficient cells that are responsible for pre-
senting antigen and inducing apoptosis in the thymus 
appear dendritic cells that are present in the cortico-
medullary junction as well as thymic medullae'. The 
majority of dendritic cells in the thymus are lymphoid 
dendritic cells identified by their expression of CD8. 
These cells express Fas ligand are suggested to be in-
volved in regulatory function rather than activation of 
T cells", which appear appropriate.
 Since developing thymocytes are designed to die when 
they encounter the relevant antigen in the thymus, any 
MHC bound peptide that are accessible to the thymus 
should be tolerogenic. The following antigen can be 
presented in the thymus resulting in negative selection 
of specific thymocytes.
(1) Antigens expressed in the cells of the thymus, which 
include thymic epithelium, dendritic cells and T cells. 
Antigenic peptides expressed in these cells may be 
presented in association with both MHC class I and class 
II, and are tolerogenic for developing CD4 and CD8 cells.
(2) Exogenous antigens that have access to the thymus 
can also induce negative selection. When the mice were 
chronically infected with lymphocytic choriomeningitis
virus (LCMV) prior to birth, specific T cells were shown 
depleted').
(3) Some of the tissue specific antigens might leak into 
circulation, reaching developing thymocytes. Thymus-
blood barrier appears to control the access of periph-
eral antigen into the thymus, although its precise mecha-
nisms are not sufficiently understood.
Peripheral Tolerance
  Why are peripheral mechanisms of tolerance neces-
sary? The central tolerance ensures that T cells spe-
cific for peptides derived from ubiquitous self-protein 
are depleted. They can be presented by thymic APC to 
developing thymocytes inducing apoptosis, net result 
of which is negative selection of self-reactive T cells. 
However, not all self-peptides are available in the thymic 
APC. Each peripheral organ has its unique protein ex-
pression, and there should be protein expressed only 
in the periphery. (For immunologists, any organ other 
than thymus and bone marrow is peripheral organ.) 
Some of them might circulate through blood, reaching 
thymus, and induce central tolerance. However, pro-
teins expressed in the cytoplasm or attached on cell 
surface may not be able to reach thymus. Therefore, T 
cells specific for such tissue specific antigens cannot be 
depleted in the thymus. They mature in the thymus 
and become naive T cells circulating in the lymphatics 
and blood. There should be mechanisms regulating these 
self-reactive T cells, since these T cells are potentially 
hazardous to self-tissue.
 How the immune system avoids the attack of self-
reactive T cells? Since induction of tolerance results in 
loss of function or cell death, it is difficult to study 
unless we identify relevant T cells. In this respect, study 
of peripheral tolerance has been greatly benefited by the 
use of transgenic mouse models (Fig. 4). TCR transgenic 
mice enabled us to follow the fate of specific T cells 
even after they are functionally inactivated (Table 1). 
Antigen transgenic mice were also developed in which 
artificial model antigen was expressed in a particular 
tissue under the control of tissue-specific promoter 
(Table 2). However, the results of these studies varied 
greatly. Several transgenic mouse models expressing a 
neo-self-antigen exclusively in a particular tissue retained 
normal reactivity to immunogenic forms of the same 
antigen. Thus, circulating T cells ignored the peripheral 
neo-self antigen. In other transgenic models, some form 
of tolerance was actively acquired. I will discuss some 
of the representative transgenic model systems.
Table 2. Neo-self antigen transgenic mice
 Name Antigen Promoter Expression References 
CPR-Kb Kb CRP liver 68) 
 RIP-Kb Kb RIP pancreas 40) 
GFAP-Kb Kb GFAP neuroectodermal 42) 
 LCMV RIP pancreas j cells 31) 69) 
RIP-Tag SV40 T RIP pancreas 5 cells 47) 
          antigen 
RIP-OVA OVA RIP pancreas j3 cells 22,32) 
RIP-I-E E RIP pancreas 0 cells 38, 39) 
INS-HEL HEL RIP pancreas j3 cells 43) 48) 
TLK-1, -2 HEL rat thyroglobulin thyroid epithelium 48) 
                           promoter
CRP: human complement reactive protein 
RIP: rat insulin promoter 
GFAP: glial fibrillary acidic protein
Fig. 4 
Transgenic model of T cell tolerance. 
The majority of T cells in TCR transgenic mice express the 
transgenic TCR on cell surface. The fate of these cells can be 
monitored using the TCR clonotype-specific antibody. Antigen 
transgenic mice express neo-self antigen X under the control of 
an appropriate promoter. Mice expressing the neo-self antigen 
in peripheral organs, and never in the thymus, are used for 
the study on the mechanisms of T cell tolerance to peripheral 
antigens. TCR transgenic and antigen transgenic mice are 
crossed to produce F1 mice in which the majority of T cells 
are specific for the neo-self antigen.
Table 1. TCR transgenic mice often used for the study of T 
cell immunology
  Name MHC restriction Antigen TCR References 
  H-Y Db H-Y Vj38.2 27) 
  2C (allorective) Ld Vj58.2 60) 
  P14 Db LCMV Va2Vj38.1 30) 
  OT-I Kd OVA257-264 Va2Vj5 61) 
  Des allorective Kb 42) 
  R28 Ak RNase Vcc4Vj6 62) 
  2134 Ek MCC87-103 Va11VjI3 63) 64) 
 5C.C7 Ek MCC87-1o3 Val1Vj33 65) 
D01 1.10 Ad OVA 323-339 Vj8 66) 
TCR-LACK Ad LACK Va8Vj4 50) 
  3A9 Kk HEL46-61 Va3VIS8.2 67)
H-Y: male antigen 
LCMV: lymphocyte choriomeningitis virus 
OVA: ovalbumin 
MCC: moth cytochrome C 
LACK: Leishmania major LACK antigen 
HEL: hen egg lysozyme
(1) Ignorance 
 Ohashi et al. generated transgenic mice, in which the 
lymphocyte choriomeningitis viral (LCMV) glycoprotein 
(GP) was expressed in the /9 islet cells of the pancreas 
under the control of rat insulin promoter"'. The fate of 
self-reactive T cells was followed by breeding these 
transgenic mice with TCR transgenic mice whose 
transgenic receptor is specific for LCMV GP. Specific 
T cells in the double transgenic mice were not acti-
vated or depleted. They ignored the presence of neo-
self antigen. However, when the mice were infected with 
LCMV, specific T cells were activated and attacked islet 
9 cells resulting in CD8+ cell-mediated diabetes. Similar 
observation was made in transgenic mice expressing 
ovalbumin in pancreatic l9 cells. When the mice were 
fed with ovalbumin, self-reactive T cells were acti-
vated, leading to the onset of autoimmune diabetes"'. 
These studies indicate that naive T cells do not neces-
sarily recognize self-proteins expressed in the periph-
ery. It appears that they ignore peripheral antigen when 
the level of protein expression is low, or when appropri-
ate co-stimulatory signal is not provided. However, once 
specific T cells are activated by the local infection or 
inflammation, they recognize those self-antigen, induc-
ing autoimmune disease. This type of self-reactivity in 
the periphery may also occur against antigens expressed 
in the thymus"'. In TCR V/98.1 transgenic mice, some 
of the self-superantigen specific T cells escape thymic 
negative selection and become mature peripheral T cells. 
These T cells become auto-reactive when activated by 
environmental stimuli","'. This type of autoreactivity 
is observed probably because the threshold of thymic 
negative selection is lower than that of re-activation of 
previously activated peripheral T cells".'
(2) Anergy 
 T cell anergy can be induced in mature T cells in vivo 
by inoculation of superantigen36.37'. It also occurs in T 
cells reactive to tissue specific antigens as demonstrated 
in some transgenic mouse models. In the transgenic
mice in which MHC class II I-E was expressed in pan-
creatic 9 cells, specific T cells were not depleted but 
were unresponsive to the TCR stimulation","). CD8 
cytotoxic T cells also can become unresponsive to TCR 
occupancy. When transgenic mice expressing allogenic 
MHC class I Kb in islet 9 cells were crossed with TCR 
transgenic mice expressing Kb-specific TCR, peripheral 
CD8 T cells became unresponsive to antigenic stimula-
tion and the mice did not develop autoimmune diseas 
e4°,41>. When these transgenic mice were crossed with 
transgenic mice expressing interleukin 2 in /3 cells of 
the pancreas, the triple transgenic mice developed dia-
betes. It is not clear, whether anergy is an established 
state of long lasting peripheral tolerance or is a tran-
sient state of tolerant T cells undergoing apoptosis.
(3) TCR modulation 
 In a transgenic mouse model, MHC class I Kb was 
expressed under the control of the glial fibrillary acidic 
protein promoter in cells of neuroectodermal origin 
outside the thymus"). When these mice were crossed 
with transgenic mice expressing Kb specific TCR, spe-
cific T cells disappeared from the periphery. These 
cells, however, reappeared in culture, suggesting that 
these self-specific T cells down regulated TCR and 
CD8 molecules in vivo. This mechanism was proposed 
as one of peripheral tolerance, but it is unclear how 
much this type of tolerance contributes self-tolerance 
in normal animals. It is not common that cells, which 
do not express TCR in vivo, gain its expression in 
vitro.
(4) Clonal diversion 
 Transgenic mice expressing an influenza hemaggluti-
nin (HA) on islet 9 cells were crossed with TCR 
transgenic mice specific for a MHC class II-restricted 
HA peptide 431. Double transgenic mice showed either 
resistance or susceptibility to spontaneous diabetes de-
pending on the genetic background, which was not 
linked to MHC. Functional studies on autoreactive CD4 
T cells from resistant mice showed that they were pre-
disposed toward differentiation to Th2 phenotype, which 
is not pathogenic. These CD4 cells from the resistant 
double transgenic mice showed evidence of prior acti-
vation by antigen, suggesting that the disease might 
be actively suppressed by autoreactive Th2 cells. There-
fore, functional deviation of CD4 cell differentiation 
appears also a mechanism to avoid autoimmune dis-
eases in the case of antigen presented by MHC class II.
(5) Deletion 
 Clonal deletion of T cells also is one of the mechanisms 
of peripheral T cell tolerance. Inoculation of superantigen
into mice in vivo induces specific T cell proliferation, 
followed by deletion","'. Also, cross-presentation of neo-
self-antigens can induce peripheral T cell tolerance 
by deletion of autoreactive CD8 T cells22>. CD95 (Fas) 
appear to be involved in the deletion of autoreactive 
CD8 T cells in the secondary lymphoid organs in this 
system").
Autoimmunity
 In the transgenic model systems, there were several 
cases in which self-tolerance was not established. I will 
discuss factors that might be involved in the patho-
genesis of autoimmune diseases in these model systems.
(1) Number of autoreactive T cells 
 When there were too many autoreactive T cells, self-
tolerance could not be maintained"). SV40 T antigen-
specific TCR transgenic mice expressing the transgenic 
TCR on either 10% or 90% of peripheral T cells were 
crossed to the transgenic mice expressing the antigen in 
pancreatic > cells. Mice expressing the transgenic TCR 
on 10% of T cells showed partial deletion of SV40-
specific T cells in the periphery and unresponsiveness 
of those that remained. In contrast, crossbred mice in 
which transgenic T cells comprised a majority of T 
cell population were not tolerant.
(2) Local concentration of self-antigen 
 The concentration of self-antigen in a discrete organ 
also affects the responsiveness of the antigen-specific 
peripheral T cells"). Hen egg lysozyme (HEL) was ex-
pressed on the thyroid epithelium, pancreatic (3-cells or 
systematically using rat throglobulin promoter, insulin 
promoter or MHC class I promoter, respectively. These 
mice were crossed with TCR transgenic mice whose TCR 
is specific for HEL, and the development of tolerance/ 
autoimmunity was investigated. Autoreactive T cells 
were present in the periphery and initiated autoimmune 
inflammation when self-antigen was concentrated in 
the thyroid or pancreas.
(3) Local environment 
 Local environment also affects the etiology of auto-
immune disease. In transgenic mouse models in which 
neo-self antigen was expressed in pancreatic fl cells, 
the tolerant state was broken resulting in autoimmune 
disease when IL-24l) or IFN-y 49) was co-expressed in the 
target organ. These cytokines may directly or indirectly 
influence activation state of the specific T cells. It is also 
likely, that local APC were activated by these cytokines 
resulting in priming of the specific T cells in the draining
lymph nodes. Alternatively, local cytokine environment 
can down-regulate autoimmune attack by T cells. Trans-
genic mice expressing TNF- a and Leishmania major 
LACK antigen in the pancreatic /9 cells exhibited im-
paired ability to mount a T cell response against LACK, 
suggesting modulation of the self-reactive T cell response 
by this cytokine50'. Recently, the involvement of CD30 in 
the regulation of autoreactive T cells in the periphery 
was demonstrated"'. In this model, OVA specific CD8 
T cells from CD30 knockout mice were transferred into 
transgenic mice expressing OVA in pancreatic islet /9 
cells. They were much more auto-aggressive than wild-
type cells, leading to the complete destruction of pan-
creatic islets and the rapid onset of diabetes. CD30 sig-
naling appears to limit the aggregation potential of CD8 
effector T cells, and protects the organ from autoimmune 
attack.
Self-tolerance vs. host defense
 Microbes that infect only non-hematopoietic tissue 
cannot directly activate naive CD8 T cells. The anti-
gen derived from such microbes has to be taken up by 
professional APC and cross-presented to CD8 cells 
(Fig. 5). Likewise, self-antigens expressed in the pe-
ripheral tissue can be presented by professional APC 
under certain conditions"'. If so, how immune system 
distinguishes pathogens and self-antigens to which T 
cells should be primed and tolerized, respectively? The 
answer is not completely clear, but several possibilities 
can be considered.
(1) Self-antigens are presented continuously while an-
tigens derived from pathogens are presented only dur-
ing the infection. T cells are tolerized when antigen is 
continuously presented by APC ever since the immune 
system is established, while they are activated when 
antigen become available transiently later in life. For 
some antigens which are present in the periphery at 
relatively high concentrations, self-antigens appear con-
tinuously presented by dendritic cells in the draining 
lymph nodes leading to apoptosis of reactive T cells. 
However, not all self-antigens may be continuously 
presented. Also, some self-proteins may be expressed 
later in life or their expression may fluctuate during 
the life of the individual.
(2) Dendritic cells, the most prominent professional 
APC, need to be activated in order to stimulate naive 
CD8 cells (Fig. 5). This activation signal comes from 
CD4 helper cells via CD40-CD40 ligand interaction, 
cytokine TNF-a or LPS derived from gram-negative
Fig. 5 
Multiple steps in T cell activation vs. inactivation 
TNF-a, CD40 ligand, or products of microbes (danger signal) 
activate dendritic cells in the peripheral tissue. Activated 
dendritic cells carry antigens to the draining lymph nodes 
where they activate specific T cells. Activated T cells differ-
entiate to effector cells and migrate to the periphery where 
they exert their effector function. The immune response is regu-
lated in each step of this pathway.
bacteria5z.53,54'. In the absence of this signal, dendritic 
cells cannot activate naive CD8 cells. After pathogen 
infect peripheral tissue, the initial host defense medi-
ated by macrophages or granulocytes results in local 
production of cytokines including TNF- a , and activa-
tion of local APC. The product of microbes themselves, 
such as LPS, can also activate dendritic cells". The 
dendritic cells activated by this local environment 
carry pathogen-derived antigens to the draining lymph 
nodes where they activate specific T cells. This environ-
ment, which activates dendritic cells, was termed "dan-
ger signal" by Polly Matzinger55'. In contrast, dendritic 
cells, which derive from non-inflammatory tissue, are 
resting cells, and may not be able to activate T cells 
in the draining lymph nodes.
 The "danger signal" may also be delivered by the 
local stress responses. Heat shock proteins up regu-
lated by stress responses may stimulate T cells ex-
pressing y8 T cell receptor") or monocytes5" resulting in 
cytokine production. Finally, it should be noted that 
the regulation of this danger signal is not simple. IL-
10 has been shown to convert dendritic cells into tol-
erance inducing form"). Although physiological role of 
this effect is unclear, it is conceivable that the activity
of dendritic cells can be regulated both positive and 
negative directions depending on the local environ-
ment.
(3) There are regulatory T cells which suppress activ-
ity of self-reactive T cells in the peripheral T cell pool. 
They are CD25+CD4+ subset of mature T cells, which 
constitute 5-10% of peripheral CD4+ T cells in mice"'. 
Elimination of this population leads to spontaneous de-
velopment of various tissue specific autoimmune dis-
eases. The effector phase of these regulatory T cells 
appears non-specific. It is unclear how these regulatory 
T cells relate to the mechanisms of specific T cell acti-
vation/inactivation described in this review.
Summary
at multiple levels, the elucidation of which is attrac-
tive and challenging. Finally, understanding of these 
mechanisms is crucial for the improved care of pa-
tients of immune-related diseases as well as the devel-
opment of novel vaccines. Improvement of the protec-
tive immunity is important for treatment of patients 
with infectious diseases and cancer, while down regu-
lation of the specific immunity is crucial for patients 
of transplantation, autoimmune diseases, and allergic 
responses.
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 Recent advances in immunology have uncovered va-
rieties of mechanisms underlying self-tolerance. They 
include clonal deletion, clonal anergy, ignorance, recep-
tor modulation, and clonal diversion. These mechanisms 
are manifested at several levels during T cell matura-
tion and activation. First and perhaps the most impor-
tant step is thymic negative selection, where developing 
thymocytes that encounter any antigen are specifically 
tolerized. Self-reactive T cells that escape this selection 
has to undergo peripheral mechanisms of tolerance (Fig. 
5). Here, the second level of T cell tolerance occurs in 
the secondary lymphoid organs. Since naive T cells 
recirculate through lymphatics and blood, peripheral 
antigen has to be taken up by local APC and carried 
to the draining lymph nodes to inactivate specific T 
cells. If self-reactive T cells are activated, they migrate 
to the tissue where the antigen is expressed. The third 
level of resistance to autoimmunity appear to present 
at the target tissue, which can be broken down by the 
local cytokine environment. In addition to these mecha-
nisms, T cells of CD4+CD25+ phenotype suppress organ 
specific autoimmune diseases by mechanisms yet to be 
known.
 Peripheral mechanisms of self-tolerance occur at multi-
ple steps, which are similar to the induction of immune 
responses. How does immune system distinguish self-
antigen to which response has to be avoided and for-
eign antigen to which it should attack? The precise 
mechanisms have not been elucidated, but "danger 
model" is an attractive idea. In this way, the mecha-
nisms of immune system, which distinguishes self- vs. 
foreign-antigen, are expressed not at the level of single 
cell type, but are operationally manifested in a whole 
immune system. It is a complex system being regulated
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